Aeglea BioTherapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Aeglea BioTherapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aeglea BioTherapeutics Inc
Rating: 1.68058325
Author: Trendlyne DVM scores

about

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient...

16.29 -0.60 (-3.55%)

333.2K

XNAS Volume

XNAS 18 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

8.3 / 100

Technically Neutral

58.9 / 100

No estimates available

Aeglea BioTherapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aeglea BioTherapeutics Inc Live Share Price Today, Share Analysis and Chart

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient...

SWOT Analysis

Aeglea BioTherapeutics Inc Live Price Chart